Biapenem

This classification denotes a beta-lactam antibiotic with the molecular formula C15H18N4O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier YR5U3L9ZH1, chemically known as 6-(((4r,5s,6s)-2-carboxy-6-((1r)-1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo(3.2.0)hept-2-en-3-yl)thio)-6,7-dihydro-5h-pyrazolo(1,2-a)-s-triazol-4-ium hydroxide, inner salt but generally known as biapenem, which bears US NIH Compound Identifier 71339. European Medicines Agency schedules Biapenem in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05813MIG. The term BIAPENEM is an International Non-Proprietary Name. World Health Organization schedules biapenem in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule biapenem under HS 29419000 and SITC 54139. As of Q4 2014, BIAPENEM remains the US FDA Preferred Term for this commodity. Biapenem bears US NLM identifiers UMLS ID C0209475 and NCI Concept Code C72620. SMILES: S(C1=C(N2C(C(C2=O)C(O)C)C1C)C(=O)O)C1C[N]2N(C1)CNC2.